Jay Venkatesan - Feb 12, 2025 Form 3 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Jay R. Venkatesan
Stock symbol
SER
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
3
Date filed
2/13/2025, 05:02 PM
Previous filing
Nov 29, 2024
Next filing
Apr 10, 2025

No securities are beneficially owned.